| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/05/2013 | US20130230488 Method for inducing immunity with a peptide fragment from human caprin-1 |
| 09/05/2013 | US20130230487 Immunomodulatory Methods and Systems for Treatment and/or Prevention of Hypertension |
| 09/05/2013 | DE19655440B4 Fixing of bearing bolt in valve rocker levers - involves annealing bolt ends to obtain their spreadability |
| 09/04/2013 | EP2634196A1 Anti-mesothelin antibodies and uses therefor |
| 09/04/2013 | EP2634194A1 Anti-cdh3 antibody having high internalization capacity |
| 09/04/2013 | EP2633867A1 Vaccine for protection against Lawsonia intracellularis, Mycoplasma hyopneumoniae and Porcine circo virus |
| 09/04/2013 | EP2633866A2 Combination therapy |
| 09/04/2013 | EP2633855A1 Protease inhibitors for treating Trichomonas gallinae infections |
| 09/04/2013 | EP2633054A1 New compositions and methods for treatment of autoimmune and allergic diseases |
| 09/04/2013 | EP2632954A1 Means and methods for treating dlbcl |
| 09/04/2013 | EP2632953A1 Antibodies for the treatment of hiv |
| 09/04/2013 | EP2632952A2 Anti-sod1 antibodies and uses thereof |
| 09/04/2013 | EP2632950A1 Method for preventing myocardial infarction-related complications |
| 09/04/2013 | EP2632949A1 Clostridium difficile-specific antibodies and uses thereof |
| 09/04/2013 | EP2632947A2 Non-antagonistic egfr-binding molecules and immunoconjugates thereof |
| 09/04/2013 | EP2632942A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same |
| 09/04/2013 | EP2632941A2 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same |
| 09/04/2013 | EP2632562A1 Methods for capturing virus like particles from plants using expanded bed chromatography |
| 09/04/2013 | EP2632492A1 METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS |
| 09/04/2013 | EP2632491A2 Enhanced cancer treatment and monitoring using recombinant vectors |
| 09/04/2013 | EP2632490A2 Novel egfr-binding molecules and immunoconjugates thereof |
| 09/04/2013 | EP2632489A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| 09/04/2013 | EP2632488A1 Immunogenic compositions and methods for treating neurologic disorders |
| 09/04/2013 | EP2632487A2 Viral vaccine and process for preparing the same |
| 09/04/2013 | EP2632486A1 Method of rapidly producing vaccines for animals |
| 09/04/2013 | EP2632485A1 Recombinant subunit dengue virus vaccine |
| 09/04/2013 | EP2632484A2 Filovirus fusion proteins and their uses |
| 09/04/2013 | EP2632483A2 Immunogenic composition |
| 09/04/2013 | EP2632482A2 Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies |
| 09/04/2013 | EP2632481A1 Therapeutic composition for treatment of glioblastoma |
| 09/04/2013 | EP2632434A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| 09/04/2013 | CN103282495A Novel anti-dr5 antibody |
| 09/04/2013 | CN103282494A C18orf54 peptides and vaccines including the same |
| 09/04/2013 | CN103282385A Fusion proteins for HIV therapy |
| 09/04/2013 | CN103282380A Erythrocyte-binding therapeutics |
| 09/04/2013 | CN103282375A Peptide scaffold design |
| 09/04/2013 | CN103282054A A pharmaceutical composition of a complex of an anti-ig antibody and digoxigenin that is conjugated to a peptide |
| 09/04/2013 | CN103282050A Antitumor combinations containing antibodies recognizing specifically CD38 and bortezomib |
| 09/04/2013 | CN103282049A 免疫原性组合物 The immunogenic composition |
| 09/04/2013 | CN103282048A The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals |
| 09/04/2013 | CN103282047A Use of anti third party central memory t cells for anti-eukemia/lymphoma treatment |
| 09/04/2013 | CN103282042A Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph |
| 09/04/2013 | CN103282023A Rabies glycoprotein virus-ike particles (vlps) |
| 09/04/2013 | CN103278634A Application of CD73 as stem cell surface marker of renal clear cell carcinoma |
| 09/04/2013 | CN103276003A Immunological regulation type chicken E.tenella resistant recombinant lactobacillus and preparation method thereof |
| 09/04/2013 | CN103275939A Recombinant virus of chimeric IBV H120 S1 gene ectodomain suitable for cell culture and construction method and application thereof |
| 09/04/2013 | CN103275938A Preparation method of PCV2 (Porcine Circovirus2)-D |
| 09/04/2013 | CN103275937A Recombinant virus expressing PCV2 codon optimized ORF1 and ORF2 tandem gene |
| 09/04/2013 | CN103275914A Bacterial ghost presenting protective antigens and application thereof |
| 09/04/2013 | CN103275912A Enterohemorrhagic Escherichia coli (EHEC) O157:H7 multivalent fliC-hcpA-tir-eae recombinant bacteria and vaccines |
| 09/04/2013 | CN103275890A Vibrio anguillarum (listonella anguillarum) virulent strain and application thereof |
| 09/04/2013 | CN103275228A K99-987P-F41 recombinant protein and application thereof |
| 09/04/2013 | CN103275227A AXL antibodies |
| 09/04/2013 | CN103275226A Preparation, identification and application of monoclonal antibodies of specific anti-human EpCAMs (epithelial cell adhesion molecules) |
| 09/04/2013 | CN103275222A Monoclonal antibody for blocking 12p40 function of interleukin as well as coding gene and application thereof |
| 09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
| 09/04/2013 | CN103275220A The ED-A antigen of fibrinogen associated with the neovasculature of tumour metastases |
| 09/04/2013 | CN103275212A Antihuman CD146 monoclone antibody, composition containing same, and method for testing dissolubility CD146 |
| 09/04/2013 | CN103275182A CD8+T cell dominant epitopes based on toxoplasmagondii bradyzoite antigens |
| 09/04/2013 | CN103272233A Application of MLL (mixed lineage leukemia) 1 antibody and expression inhibiter in preparing medicine for treating AML (acute myeloid leukemia) |
| 09/04/2013 | CN103272232A Preventive or remedy for inflammatory disease |
| 09/04/2013 | CN103272231A Vaccine for immunizing sheep for producing twins and preparation method thereof |
| 09/04/2013 | CN103272230A Triple vaccine special for Muscovy duck |
| 09/04/2013 | CN103272229A Oral agent for blocking prawns from infecting white spot syndrome viruses, and preparation method and application thereof |
| 09/04/2013 | CN103272228A Biological control method of crucian hemorrhagic disease and application thereof |
| 09/04/2013 | CN103272227A Peptides for desensibilization against allergens |
| 09/04/2013 | CN102796763B Preparation method and application of carp spermary bioreactor |
| 09/04/2013 | CN102719407B Porcine parvovirus BQ-C strain and application of porcine parvovirus BQ-C strain in preparation of inactivated porcine parvovirus vaccine |
| 09/04/2013 | CN102657599B Method for preparing bioactive injectable hydrogel materials for oncotherapy |
| 09/04/2013 | CN102617734B Antibody Dab-2 against FGF-2 and application thereof |
| 09/04/2013 | CN102586195B Method for preparing avian influenza virus and inactivated vaccine thereof with Vero passage cells |
| 09/04/2013 | CN102526725B Adenosine triphosphate (ATP) and aluminium hydroxide composite adjuvant and vaccine containing same |
| 09/04/2013 | CN102526721B Inactivated vaccine for ictalurus punctatus hemorrhage disease, as well as preparation method and application thereof |
| 09/04/2013 | CN102406929B Co-expressed molecular adjuvant enhanced divalent foot and mouth disease protein engineering vaccine |
| 09/04/2013 | CN102210861B Multi-epitope peptide-loaded DC (dendritic cell) therapeutic vaccine for HCV (hepatitis C viruses) |
| 09/04/2013 | CN101842388B Humanized antibodies against the beta-amyloyd peptide |
| 09/04/2013 | CN101687908B Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 09/04/2013 | CN101676388B Avian cell lines for the production of useful substances |
| 09/04/2013 | CN101633689B Peptide selection method |
| 09/04/2013 | CN101541828B Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 09/04/2013 | CN101505794B scFV antibodies which pass epithelial and/or endothelial layers |
| 09/04/2013 | CN101454022B Pseudoinfectious flavivirus and uses thereof |
| 09/04/2013 | CN101415729B Antibodies against amyloid-beta peptide |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/04/2013 | CN101166827B Expression of proteins in plants |
| 09/04/2013 | CN101065667B Methods of diagnosing and treating complications of pregnancy |
| 09/03/2013 | USH2284 Vaccines for protecting against influenza |
| 09/03/2013 | USH2283 Vaccines for protecting against influenza |
| 09/03/2013 | US8524872 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer |
| 09/03/2013 | US8524869 Humanized antibodies against LIGHT and uses thereof |
| 09/03/2013 | US8524868 Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 09/03/2013 | US8524867 Optimized antibodies that target CD19 |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524667 Methods of treating gout using IL-1BETA antibodies |
| 09/03/2013 | US8524660 Polyalkylene polymer compounds and uses thereof |
| 09/03/2013 | US8524497 Animal protein free media for cultivation of cells |
| 09/03/2013 | US8524491 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated |
| 09/03/2013 | US8524482 Method and system for sampling and separating submicron-sized particles based on density and or size to detect the presence of a particular agent |
| 09/03/2013 | US8524461 Multiple antigenic peptide assay for detection of HIV or SIV type retroviruses |
| 09/03/2013 | US8524460 PSCA: prostate stem cell antigen and uses thereof |